ABSTRACT
INTRODUCTION
than 100 KMTs (10, 11) , and these enzymes catalyze methylations on numerous proteins other than histones (6, (12) (13) (14) (15) . In fact, based on data curated Numerous biochemical and structural studies in the past two decades have uncovered protein substrate binding by various catalytic domains of KMTs (14, 17, 18) . The converging picture is that the catalytic domain of KMTs recognize 2-3 residues flanking both N-and Ctermini of methylating Lys residue (14) .
If each KMT indeed only recognizes such short linear substrate recognition motifs, many KMTs would share overlapping substrates and methylation reactions would be highly promiscuous, a deduction that appears to be contradictory to numerous functional studies of lysine methylations both on histone and non-histone proteins (19) .
Furthermore, taking several better studied KMTs such as SETD7 (aka SET7/9 and KMT7), G9a (also known as Identification of such KMT-substrate specificity mechanisms will not only be vital for understanding functional implications of each lysine methylation, but also be crucial for selecting KMTs as drug targets for disease therapies.
SETD7 is the first KMT that was identified to be able to methylate Lys residues both in histones and non-histone proteins (20) (21) (22) interaction ( Figure 1C , 1D and S1A, B&E). Interestingly, deletion of the N terminal 51 residues dramatically diminished the binding ( Figure 1C and Figure S1C ; this 51-residue was not defined in the crystal structure of SETD7; (17, 35) ), indicating that the intact MORN repeats are required for binding to PDX1.
The PDX1_HOX is known to bind to specific DNA sequence with a high affinity (39) ( Figure S1D ). We then asked To test this hypothesis, we selected nine transcription factors from four different classes (40) and tested their bindings to SETD7 using GST pull-down assay ( Figure 1H ). DNA binding domains of these transcription factors were purified as Trx-fused proteins. Strikingly, every one of these transcription factors could be pulled down by GST-SETD7_MORN in low salt concentration assay buffer (100 mM NaCl; Figure 1H and 1I). Again, all these interactions were dramatically weakened or even disrupted by raising NaCl concentration to 500 mM in the assay buffer ( Figure 1H and 1I). We have verified the direct bindings of some of these transcription factors to SETD7
by FPLC by mixing each of purified DNA binding domains with SETD7_FL
( Figure S3 ). We have also shown that a specific MyoD binding DNA duplex (41) specifically disrupted the interaction between SETD7 and MyoD (42) ( Figure   S2B ). The N-terminal tail of histone H3 was reported to be mono-methylated at
Lys4 by SETD7 and is highly positively Similarly, PDX1-specific and CDX1-specific DNA sequences could inhibit the TAF10_P/PDX1_HOX chimera ( Fig. 3) and CDX1 (Fig. 4) 
EXPERIMENTAL PROCEDURES

Constructs and Protein Expression
The full-length SETD7 (NCBI Accession Number: NP_542983. 
